Compare PRLD & HCKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PRLD | HCKT |
|---|---|---|
| Founded | 2016 | 1991 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Professional Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 260.2M | 249.5M |
| IPO Year | 2020 | 1998 |
| Metric | PRLD | HCKT |
|---|---|---|
| Price | $3.65 | $13.44 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 3 |
| Target Price | $9.20 | ★ $17.33 |
| AVG Volume (30 Days) | ★ 336.1K | 207.4K |
| Earning Date | 11-20-2026 | 11-03-2026 |
| Dividend Yield | N/A | ★ 3.61% |
| EPS Growth | ★ 23.21 | N/A |
| EPS | N/A | ★ 0.49 |
| Revenue | $12,140,000.00 | ★ $285,862,000.00 |
| Revenue This Year | $258.83 | N/A |
| Revenue Next Year | N/A | $3.57 |
| P/E Ratio | ★ N/A | $27.10 |
| Revenue Growth | ★ 73.43 | N/A |
| 52 Week Low | $1.17 | $9.16 |
| 52 Week High | $6.83 | $20.68 |
| Indicator | PRLD | HCKT |
|---|---|---|
| Relative Strength Index (RSI) | 45.05 | 73.34 |
| Support Level | $3.38 | $12.39 |
| Resistance Level | $4.12 | $14.30 |
| Average True Range (ATR) | 0.33 | 0.55 |
| MACD | 0.04 | 0.10 |
| Stochastic Oscillator | 35.71 | 64.88 |
Prelude Therapeutics Incorp is a precision oncology company developing medicines in areas of high unmet need for cancer patients. Its pipeline features selective KAT6A degraders and mutant selective JAK2V617F JH2 inhibitors, new approaches to clinically validated targets with transformative potential for patients. The company is also leveraging its expertise in targeted protein degradation to discover and develop next-generation degrader antibody conjugates (DACs) with novel payloads.
The Hackett Group Inc is an IP platform-based Generative Artificial Intelligence (Gen AI) strategic consulting and executive advisory digital transformation firm. The Hackett Group provides dedicated expertise in Gen AI-enabled enterprise transformation services across the front, mid and back office areas, including its highly recognized Oracle, SAP, OneStream and Coupa implementation offerings. It operates in three segments Oracle Solutions, SAP Solutions, and Global S&BT. It generates the majority of its revenue from the Global S&BT segment in the United States.